← Leaderboards
Rachel Genova
University Of Iowa
$159,755
Attributed
$159,755
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2016–19$100K$75K$50K$25K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$159,755 · 1
By mechanism
F30$159,755 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Mark Anthony Yorek$7,990,158
- Jackie R Bickenbach$3,774,302
- Huojun Cao$2,959,197
- Toshihiro Kitamoto$5,338,854
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAcidsAdultAffectAdhesionsAlternative TherapiesAnatomyAnimalsAnteriorAreaAttentionAlkaliesAxon RegenerationAxotomyBaseBilateralBlindnessBurn InjuryCataractCell DeathCellsCellular TargetingChemical EliminationChemical Exposure
Grant awards (4)
Therapeutic efficacy and mechanism of (-)-P7C3-S243 and P18C8 coadministration in a model of chemical corneal injury$50,016
F30 · FY2019 · EY · contact PI
Therapeutic efficacy and mechanism of (-)-P7C3-S243 and P18C8 coadministration in a model of chemical corneal injury$42,520
F30 · FY2018 · EY · contact PI
Therapeutic efficacy and mechanism of (-)-P7C3-S243 and P18C8 coadministration in a model of chemical corneal injury$33,901
F30 · FY2017 · EY · contact PI
Therapeutic efficacy and mechanism of (-)-P7C3-S243 and P18C8 coadministration in a model of chemical corneal injury$33,318
F30 · FY2016 · EY · contact PI